what was the revenue from, page-28

Snork, having looked at the magnitude ($) of the deals landed by the company to date, what is the scale of the "big contract" that is reasonable to expect?

Was Sanofi big? I know when AS was talking to the delays with the deal talked about in May, he said he was not worried and working on other deals. I recall he said one could be possibly larger that what turned out to be Sanofi.

So, would be great if the Dec '12 US pharma that was meant to be targetting Unifill for a number of pipeline and existing drugs popped up. I have always felt that after 12 months a pharma that was keen on market launch would be well and truly able to sign a supply agreement for Unifill to allow migrating the drug from a typical prefill to a Unifill.

I suppose that’s why i was in part surprised that Sanofi chose an existing drug as their timelines are rather longer than what is achievable for changing primary containers. IMO their timeframe is more along what I expected for a pipeline drug, not approved therapeutic.

If they can bag over 60% of their 2014 cash burn than I will be pretty happy with progress. I am hoping lightnting may strike, but not investing on the belief that it will